In melanoma cells, the expression of particular molecules, such as colony-stimulator factor 1 (CSF1) or CD47, in response to T-cell derived cytokines represents a conserved and adaptive resistance mechanism involved in disease progression [34]. Here, CD47 is linked to melanoma.